Anthony Digiandomenico - Net Worth and Insider Trading

Anthony Digiandomenico Net Worth

The estimated net worth of Anthony Digiandomenico is at least $5 Million dollars as of 2025-05-28. Anthony Digiandomenico is the Director of Provention Bio Inc and owns about 178,712 shares of Provention Bio Inc (PRVB) stock worth over $4 Million. Anthony Digiandomenico is the Co-Founder, 10% Owner of MDB Capital Holdings LLC and owns about 95,699 shares of MDB Capital Holdings LLC (MDBH) stock worth over $359,828. Anthony Digiandomenico is also the Director of Cue Biopharma Inc and owns about 57,000 shares of Cue Biopharma Inc (CUE) stock worth over $37,136. Besides these, Anthony Digiandomenico also holds ENDRA Life Sciences Inc (NDRA) . Details can be seen in Anthony Digiandomenico's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Anthony Digiandomenico has not made any transactions after 2025-04-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Anthony Digiandomenico

Anthony Digiandomenico Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Anthony Digiandomenico owns 7 companies in total, including ENDRA Life Sciences Inc (NDRAU) , Provention Bio Inc (PRVB) , and Cue Biopharma Inc (CUE) among others .

Click here to see the complete history of Anthony Digiandomenico’s form 4 insider trades.

Insider Ownership Summary of Anthony Digiandomenico

Ticker	Company	Transaction Date	Type of Owner
NDRAU	ENDRA Life Sciences Inc	2020-07-21	director
PRVB	Provention Bio Inc	2019-09-30	director
CUE	Cue Biopharma Inc	2018-12-28	director
		2004-08-06	director
		2004-12-17	director
		2023-05-02	director
		2025-02-13	director & 10 percent owner & Chief of Transactions

Anthony Digiandomenico Latest Holdings Summary

Anthony Digiandomenico currently owns a total of 4 stocks. Among these stocks, Anthony Digiandomenico owns 178,712 shares of Provention Bio Inc (PRVB) as of September 30, 2019, with a value of $4 Million and a weighting of 91.83%. Anthony Digiandomenico owns 95,699 shares of MDB Capital Holdings LLC (MDBH) as of April 7, 2025, with a value of $359,828 and a weighting of 7.4%. Anthony Digiandomenico also owns 57,000 shares of Cue Biopharma Inc (CUE) as of December 28, 2018, with a value of $37,136 and a weighting of 0.76%. The other 1 stocks ENDRA Life Sciences Inc (NDRA) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Anthony Digiandomenico

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
PRVB	Provention Bio Inc	2019-09-30	178,712	24.98	4,464,226
MDBH	MDB Capital Holdings LLC	2025-04-07	95,699	3.76	359,828
CUE	Cue Biopharma Inc	2018-12-28	57,000	0.65	37,136
NDRA	ENDRA Life Sciences Inc	2023-05-02	59	3.09	182

Holding Weightings of Anthony Digiandomenico

Anthony Digiandomenico Form 4 Trading Tracker

According to the SEC Form 4 filings, Anthony Digiandomenico has made a total of 0 transactions in Provention Bio Inc (PRVB) over the past 5 years. The most-recent trade in Provention Bio Inc is the acquisition of 30,000 shares on September 30, 2019, which cost Anthony Digiandomenico around $204,900.

According to the SEC Form 4 filings, Anthony Digiandomenico has made a total of 11 transactions in MDB Capital Holdings LLC (MDBH) over the past 5 years, including 11 buys and 0 sells. The most-recent trade in MDB Capital Holdings LLC is the acquisition of 1,425 shares on April 7, 2025, which cost Anthony Digiandomenico around $6,983.

According to the SEC Form 4 filings, Anthony Digiandomenico has made a total of 0 transactions in Cue Biopharma Inc (CUE) over the past 5 years. The most-recent trade in Cue Biopharma Inc is the acquisition of 7,000 shares on December 28, 2018, which cost Anthony Digiandomenico around $32,340.

More details on Anthony Digiandomenico's insider transactions can be found in the Insider Trading History of Anthony Digiandomenico table.

Insider Trading History of Anthony Digiandomenico

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Anthony Digiandomenico Trading Performance

GuruFocus tracks the stock performance after each of Anthony Digiandomenico's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anthony Digiandomenico is 11.24%. GuruFocus also compares Anthony Digiandomenico's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anthony Digiandomenico within 3 months outperforms 17 times out of 35 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Anthony Digiandomenico's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Anthony Digiandomenico

Average Return

Average return per transaction

Outperforming Transactions

24 out of 25 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	6.42
Relative Return to S&P 500(%)	4.88

Anthony Digiandomenico Ownership Network

Ownership Network List of Anthony Digiandomenico

No Data

Ownership Network Relation of Anthony Digiandomenico

Anthony Digiandomenico Owned Company Details

What does ENDRA Life Sciences Inc do?

Who are the key executives at ENDRA Life Sciences Inc?

Anthony Digiandomenico is the director of ENDRA Life Sciences Inc. Other key executives at ENDRA Life Sciences Inc include Chief Commercial Officer Renaud Bertrand Maloberti , Chief Technology Officer Michael Milos Thornton , and Chief Financial Officer David R. Wells .

ENDRA Life Sciences Inc (NDRAU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ENDRA Life Sciences Inc (NDRAU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ENDRA Life Sciences Inc (NDRAU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ENDRA Life Sciences Inc (NDRAU)'s detailed insider trading history can be found in Insider Trading Tracker table.

ENDRA Life Sciences Inc Insider Transactions

No Available Data

What does Provention Bio Inc do?

Who are the key executives at Provention Bio Inc?

Anthony Digiandomenico is the director of Provention Bio Inc. Other key executives at Provention Bio Inc include 10 percent owner Sessa Capital (master), L.p. , director & 10 percent owner & Chief Scientific Officer Francisco Leon , and director & 10 percent owner & President and CEO Ashleigh Palmer .

Provention Bio Inc (PRVB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Provention Bio Inc (PRVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Provention Bio Inc (PRVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Provention Bio Inc (PRVB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Provention Bio Inc Insider Transactions

No Available Data

What does Cue Biopharma Inc do?

Who are the key executives at Cue Biopharma Inc?

Anthony Digiandomenico is the director of Cue Biopharma Inc. Other key executives at Cue Biopharma Inc include director & CEO Daniel R Passeri , President and CSO Anish Suri , and Chief Medical Officer Matteo Levisetti .

Cue Biopharma Inc (CUE) Insider Trades Summary

Over the past 18 months, Anthony Digiandomenico made no insider transaction in Cue Biopharma Inc (CUE). Other recent insider transactions involving Cue Biopharma Inc (CUE) include a net purchase of 30,000 shares made by Daniel R Passeri ,

In summary, during the past 3 months, insiders sold 0 shares of Cue Biopharma Inc (CUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cue Biopharma Inc (CUE) were sold and 30,000 shares were bought by its insiders, resulting in a net purchase of 30,000 shares.

Cue Biopharma Inc (CUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cue Biopharma Inc Insider Transactions

No Available Data

What does Charlies Holdings Inc do?

Who are the key executives at Charlies Holdings Inc?

Anthony Digiandomenico is the director of Charlies Holdings Inc. Other key executives at Charlies Holdings Inc include PRESIDENT Henry Iii Sicignano , Chief Financial Officer Matthew P Montesano , and Chief Information Officer Adam Mirkovich .

Charlies Holdings Inc (CHUC) Insider Trades Summary

Over the past 18 months, Anthony Digiandomenico made no insider transaction in Charlies Holdings Inc (CHUC). Other recent insider transactions involving Charlies Holdings Inc (CHUC) include a net purchase of 1,250,000 shares made by Michael D King , and a net purchase of 17,498 shares made by Edward Carmines .

In summary, during the past 3 months, insiders sold 0 shares of Charlies Holdings Inc (CHUC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Charlies Holdings Inc (CHUC) were sold and 1,267,498 shares were bought by its insiders, resulting in a net purchase of 1,267,498 shares.

Charlies Holdings Inc (CHUC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Charlies Holdings Inc Insider Transactions

No Available Data

What does Medivation Inc do?

Who are the key executives at Medivation Inc?

Anthony Digiandomenico is the director of Medivation Inc. Other key executives at Medivation Inc include Chief Operating Officer Marion Mccourt , VP & Finance and Accounting Tseli Lily Yang , and Interim Chief Medical Officer Mohammad Hirmand .

Medivation Inc (MDVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Medivation Inc (MDVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Medivation Inc (MDVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Medivation Inc (MDVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Medivation Inc Insider Transactions

No Available Data

What does ENDRA Life Sciences Inc do?

Who are the key executives at ENDRA Life Sciences Inc?

Anthony Digiandomenico is the director of ENDRA Life Sciences Inc. Other key executives at ENDRA Life Sciences Inc include Chief Technology Officer Michael Milos Thornton , director & Chief Executive Officer Francois Roger Michelon , and Senior Director & Finance Irina Pestrikova .

ENDRA Life Sciences Inc (NDRA) Insider Trades Summary

Over the past 18 months, Anthony Digiandomenico made no insider transaction in ENDRA Life Sciences Inc (NDRA). Other recent insider transactions involving ENDRA Life Sciences Inc (NDRA) include a net purchase of 3,715 shares made by Group Ag Ubs ,

In summary, during the past 3 months, insiders sold 0 shares of ENDRA Life Sciences Inc (NDRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ENDRA Life Sciences Inc (NDRA) were sold and 106 shares were bought by its insiders, resulting in a net purchase of 106 shares.

ENDRA Life Sciences Inc (NDRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

ENDRA Life Sciences Inc Insider Transactions

No Available Data

What does MDB Capital Holdings LLC do?

Who are the key executives at MDB Capital Holdings LLC?

Anthony Digiandomenico is the director & 10 percent owner & Chief of Transactions of MDB Capital Holdings LLC. Other key executives at MDB Capital Holdings LLC include Chief Accounting Officer Jeremy William James , director & 10 percent owner & CEO Christopher A Marlett , and director & Chief Entrepreneurship & Ops Mohammad Hayat .

MDB Capital Holdings LLC (MDBH) Insider Trades Summary

Over the past 18 months, Anthony Digiandomenico made 11 insider transaction in MDB Capital Holdings LLC (MDBH) with a net purchase of 15,965. Other recent insider transactions involving MDB Capital Holdings LLC (MDBH) include a net purchase of 3,050 shares made by Christopher A Marlett , a net sale of 6,661 shares made by Jeremy William James ,

In summary, during the past 3 months, insiders sold 0 shares of MDB Capital Holdings LLC (MDBH) in total and bought 4,475 shares, with a net purchase of 4,475 shares. During the past 18 months, 6,661 shares of MDB Capital Holdings LLC (MDBH) were sold and 19,015 shares were bought by its insiders, resulting in a net purchase of 12,354 shares.

MDB Capital Holdings LLC (MDBH)'s detailed insider trading history can be found in Insider Trading Tracker table.

MDB Capital Holdings LLC Insider Transactions

No Available Data

Anthony Digiandomenico Mailing Address

Above is the net worth, insider trading, and ownership report for Anthony Digiandomenico. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Anthony Digiandomenico's mailing address is: Ann Arbor Mi 48105.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.